Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2014

Dec 19, 2014

29777_dirs_2014-12-19_09f8f126-5b72-4067-97b8-3912a88c4adf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2014-11-28

Reporting Person: Pavee Jean-Yves (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-11-28 Common shares without par value G 5933 Disposed 27783 Direct
2014-11-28 Common shares without par value G 2967 Acquired 2967 Indirect
2014-11-28 Common shares without par value G 2966 Acquired 2966 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 2342 Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of December 18, 2014.

F2: The reporting person disclaims beneficial ownership of all securities held by his daughter.

F3: The reporting person disclaims beneficial ownership of all securities held by his son.